Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Tekmira Conference Call and Webcast Advisory: Corporate Update and Year-End 2012 Financial Results



Tekmira Conference Call and Webcast Advisory: Corporate Update and Year-End
2012 Financial Results

VANCOUVER, B.C., March 20, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals
Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference
(RNAi) therapeutics, announced that it will hold a conference call and webcast
on Wednesday, March 27, 2013 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to
provide a corporate update and report year-end 2012 financial results.

Conference Call and Webcast Information

A live webcast of the call can be accessed through the Investor section of
Tekmira's website at www.tekmirapharm.com. Or, alternatively, to access the
conference call, please dial 914-495-8556 or 1-866-393-1607.

An archived webcast will be available on the Tekmira website approximately two
hours after the event. Alternatively, to access a replay of the conference
call, please dial 404-537-3406 or 1-855-859-2056 and reference conference ID
26000337.

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on
advancing novel RNAi therapeutics and providing its leading lipid nanoparticle
delivery technology to pharmaceutical partners. Tekmira has been working in
the field of nucleic acid delivery for over a decade and has broad
intellectual property covering LNPs. Further information about Tekmira can be
found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

CONTACT: Investors
         Jodi Regts
         Director, Investor Relations
         Phone: 604-419-3234
         Email: jregts@tekmirapharm.com
        
         Media
         David Ryan
         Longview Communications Inc.
         Phone: 416-649-8007
         Email: dryan@longviewcomms.ca

Tekmira Pharmaceuticals Logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement